Astrazeneca (AZN) Free Cash Flow (2009 - 2025)
Astrazeneca (AZN) posted Free Cash Flow of $7.96 billion for Q3 2026, down 0.4% from $8 billion a year earlier but up 689.9% from the prior quarter.
Astrazeneca (AZN) Free Cash Flow (2009 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Free Cash Flow at Astrazeneca was $10.63 billion, down 22.8% year-over-year; for FY2025, it came in at $11.77 billion, up 18.4% from FY2024.
- Annual Free Cash Flow has increased for seven consecutive years, with a five-year compound annual growth rate of 25.1% (FY2020 to FY2025).
- In prior years, Astrazeneca's Free Cash Flow was $9.94 billion in FY2024 (+10.6%), $8.98 billion in FY2023 (+3.1%), $8.72 billion in FY2022 (+78.9%) and $4.87 billion in FY2021 (+26.9%).
- Quarterly Free Cash Flow has run from a low of -$2.24 billion in Q4 2025 to a high of $8 billion in Q3 2025 over five years.
- On a year-over-year basis, Free Cash Flow has declined in each of the last three quarters, with growth averaging 6.4% over the last six quarters.
- The strongest year-over-year quarter for Free Cash Flow in the past five years was Q2 2022, with growth of 239.6%; the weakest was Q2 2026, with a decline of 46.1%.
- According to Business Quant data, Free Cash Flow for the three prior quarters was $1.01 billion (Q2 2026), $3.91 billion (Q1 2026) and -$2.24 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Yr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.97 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.70 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 17.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.36 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 17.60 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 11.77 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 8.10 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 9.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 9.08 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 3.19 Bn |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 11.77 Bn |
| Dec 31, 2024 | 9.94 Bn |
| Dec 31, 2023 | 8.98 Bn |
| Dec 31, 2022 | 8.72 Bn |
| Dec 31, 2021 | 4.87 Bn |
| Dec 31, 2020 | 3.84 Bn |
| Dec 31, 2019 | 1.99 Bn |
| Dec 31, 2018 | 1.58 Bn |
| Dec 31, 2017 | 2.25 Bn |
| Dec 31, 2016 | 2.70 Bn |
| Dec 31, 2015 | 2.00 Bn |
| Dec 31, 2014 | 8.07 Bn |
| Dec 31, 2013 | 8.14 Bn |
| Dec 31, 2012 | 7.62 Bn |
| Dec 31, 2011 | 8.66 Bn |
| Dec 31, 2010 | 11.47 Bn |
| Dec 31, 2009 | 12.70 Bn |
Astrazeneca Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow-annual&ticker=AZN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow-annual", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow-annual&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();